Viability of microencapsulated probiotic bacteria in a cream/ gel-like solution for topical application

D. Moreira*, Â. Rêgo, P. Gullón, B. Gullón, F. K. Tavaria

*Autor correspondente para este trabalho

Resultado de pesquisarevisão de pares

Resumo

Introduction: Encapsulation technology has been used as a means to improve the viability of bacteria for long periods of time in hostile environments. For that, it is necessary to immobilize the bacterial cells in a matrix that can protect them from the abiotic factors surrounding them [1]. Several methods are available for that purpose, such as spray-drying, extrusion, emulsion and phase separation [2]. In this work, the spray-dryer technique was used to encapsulate probiotic bacteria in an alginate matrix. This protects and confers an extended shelf-life to the bacteria to be used in a specific application (probiotic-containing solution to be topically applied to skin). Moreover, maltodextrin was added to the alginate solution, with the purpose of creating space within the capsules, protecting the bacteria from the high temperatures attained in the spray-dryer during the process [3]. The cell viability of the microcapsules containing the probiotic was assessed throughout time and also after incorporating in the cream/gel matrix. Conclusions: Bifidobacterium lactis (Bb12) microcapsules with FOS showed more resistance to the storage. After around 45 days, the cell viability dropped ca. 4 logs for the microcapsules with FOS added. When added to the cream matrix, Bifidobacterium lactis (Bb12) microcapsules with FOS were also more resistant to the storage. After 25 days the cell viability has dropped ca. 1 log and 3.5 logs for the microcapsules with and without FOS, respectively. Encapsulation with prebiotics (FOS) seems to aid in the maintenance and stability of cell viability and the ingredients in the final formulation may confer added protection to the bacteria.
Idioma originalEnglish
Número de páginas1
Estado da publicaçãoPublicado - 2015
EventoExploring Human Host-Microbiome Interactions in Health and Disease - Wellcome Genome Campus, Cambridgeshire
Duração: 29 jun. 20151 jul. 2015

Conferência

ConferênciaExploring Human Host-Microbiome Interactions in Health and Disease
País/TerritórioUnited Kingdom
CidadeCambridgeshire
Período29/06/151/07/15

Impressão digital

Mergulhe nos tópicos de investigação de “Viability of microencapsulated probiotic bacteria in a cream/ gel-like solution for topical application“. Em conjunto formam uma impressão digital única.

Citação